or Try an Advanced Search...

    Technical Analysis for TARS - Tarsus Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 46.14 -0.96% -0.45
    TARS closed down 0.66 percent on Wednesday, November 20, 2024, on 47 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Up Up Down
    Historical TARS trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction -0.96%
    20 DMA Support Bullish -1.61%
    Outside Day Range Expansion -1.61%
    20 DMA Support Bullish 3.37%
    Wide Bands Range Expansion 3.37%
    20 DMA Support Bullish 2.91%
    Slingshot Bullish Bullish Swing Setup 2.91%
    Wide Bands Range Expansion 2.91%
    MACD Bearish Signal Line Cross Bearish -1.10%
    Pocket Pivot Bullish Swing Setup -1.10%
    Older End-of-Day Signals for TARS ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance 17 minutes ago
    Up 1% 17 minutes ago
    Possible NR7 about 20 hours ago
    60 Minute Opening Range Breakout about 23 hours ago
    Up 1% about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TARS Chart by TradingView
    Basic chart:

    Profile

    Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase IIb/III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. Tarsus Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Irvine, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Organ Systems Ophthalmic Malaria Rosacea Blepharitis Meibomian Gland

    Is TARS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade
    Nov 15 Tarsus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
    Nov 14 Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...
    Nov 14 Tarsus Pharmaceuticals, Inc. (TARS) Q3 2024 Earnings Call Transcript
    Nov 13 Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates
    Nov 13 Tarsus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.31, revenue of $48.1M beats by $4.92M
    Nov 13 Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
    Nov 13 Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
    Nov 13 Earnings Scheduled For November 13, 2024
    Nov 7 Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
    See more TARS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 52.99
    52 Week Low 15.6
    Average Volume 751,688
    200-Day Moving Average 33.07
    50-Day Moving Average 38.71
    20-Day Moving Average 45.30
    10-Day Moving Average 46.89
    Average True Range 2.81
    RSI (14) 62.26
    ADX 55.06
    +DI 33.30
    -DI 15.07
    Chandelier Exit (Long, 3 ATRs) 44.56
    Chandelier Exit (Short, 3 ATRs) 44.50
    Upper Bollinger Bands 51.03
    Lower Bollinger Band 39.56
    Percent B (%b) 0.61
    BandWidth 25.32
    MACD Line 2.38
    MACD Signal Line 2.86
    MACD Histogram -0.4832
    Fundamentals Value
    Market Cap 1.54 Billion
    Num Shares 33.1 Million
    EPS -3.84
    Price-to-Earnings (P/E) Ratio -12.13
    Price-to-Sales 72.00
    Price-to-Book 4.83
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 49.04
    Resistance 3 (R3) 49.03 48.20 48.63
    Resistance 2 (R2) 48.20 47.57 48.21 48.49
    Resistance 1 (R1) 47.39 47.19 46.98 47.40 48.36
    Pivot Point 46.56 46.56 46.35 46.57 46.56
    Support 1 (S1) 45.75 45.93 45.34 45.76 44.80
    Support 2 (S2) 44.92 45.55 44.93 44.67
    Support 3 (S3) 44.11 44.92 44.53
    Support 4 (S4) 44.12